国际肿瘤学杂志 ›› 2017, Vol. 44 ›› Issue (12): 922-925.doi: 10.3760/cma.j.issn.1673-422X.2017.12.010

• 综述 • 上一篇    下一篇

肿瘤异质性的机制、检测及临床意义

杨琪帆,刘洋洋,曾玉兰,刘玉婷,刘莉   

  1. 430022 武汉,华中科技大学同济医学院附属协和医院肿瘤中心
  • 出版日期:2017-12-08 发布日期:2017-12-01
  • 通讯作者: 刘莉,Email: liulixiehe2004@163.com E-mail: liulixiehe2004@163.com
  • 基金资助:
    国家自然科学基金(81372260)

Mechanism, detection and clinical implication of tumor heterogeneity

Yang Qifan, Liu Yangyang, Zeng Yulan, Liu Yuting, Liu Li   

  1. Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
  • Online:2017-12-08 Published:2017-12-01
  • Contact: Liu Li, Email: liulixiehe2004@163.com E-mail: liulixiehe2004@163.com
  • Supported by:
    National Natural Science Foundation of China (81372260)

摘要: 近年来,随着基因测序技术的发展,肿瘤异质性受到了人们的广泛关注。同一患者体内的肿瘤异质性包括瘤间异质性和瘤内异质性,前者见于不同病灶,如原发肿瘤与转移瘤,后者见于同一病灶内不同细胞之间。肿瘤异质性代表了癌症精准医学领域正在面临的挑战,为肿瘤的个体化治疗带来了极大困难。因此,通过异质性检测技术发现肿瘤的亚克隆,并及时调整治疗方案,有望为肿瘤患者实现精准诊断与治疗。

关键词: 肿瘤, 遗传异质性, 精准医学

Abstract: In recent years, with the rapid development of the Next Generation Sequencing, the tumor heterogeneity has attracted widespread attention. It has been clear that heterogeneity in the same patient includes inter-tumor heterogeneity and intra-tumor heterogeneity. The former exists between different tumor lesions, such as primary tumor and metastatic tumor, and the latter occurs in different cancer cells. Tumor heterogeneity represents the ongoing challenge in the field of cancer treatment and brings great difficulty for the precision medicine. Therefore, it is possible to achieve accurate diagnosis and therapy for tumor patients by detecting the subclone of tumors and adjusting the treatment plan in time.

Key words: Neoplasms, Genetic heterogeneity, Precision medicine